5.44
price down icon0.37%   -0.02
after-market Dopo l'orario di chiusura: 5.46 0.02 +0.37%
loading
Precedente Chiudi:
$5.46
Aprire:
$5.45
Volume 24 ore:
345.75K
Relative Volume:
0.29
Capitalizzazione di mercato:
$1.22B
Reddito:
$596.48M
Utile/perdita netta:
$123.72M
Rapporto P/E:
9.9198
EPS:
0.5484
Flusso di cassa netto:
$106.59M
1 W Prestazione:
+0.74%
1M Prestazione:
+1.49%
6M Prestazione:
+41.30%
1 anno Prestazione:
+51.11%
Intervallo 1D:
Value
$5.43
$5.47
Intervallo di 1 settimana:
Value
$5.38
$5.48
Portata 52W:
Value
$2.37
$5.72

Curevac N V Stock (CVAC) Company Profile

Name
Nome
Curevac N V
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
1,088
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-10
Name
Ultimi documenti SEC
Name
CVAC's Discussions on Twitter

Confronta CVAC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CVAC
Curevac N V
5.44 1.22B 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Curevac N V Stock (CVAC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-13 Downgrade Jefferies Buy → Hold
2024-04-25 Downgrade Leerink Partners Outperform → Market Perform
2023-06-08 Iniziato SVB Securities Outperform
2023-01-19 Aggiornamento UBS Neutral → Buy
2023-01-09 Aggiornamento Jefferies Hold → Buy
2022-01-21 Downgrade BofA Securities Neutral → Underperform
2022-01-18 Iniziato JMP Securities Mkt Outperform
2021-10-22 Iniziato Deutsche Bank Hold
2021-06-17 Downgrade BofA Securities Buy → Neutral
2021-04-26 Ripresa Credit Suisse Underperform
2021-04-26 Iniziato Guggenheim Neutral
2020-12-10 Downgrade Credit Suisse Neutral → Underperform
2020-09-08 Iniziato BofA Securities Buy
2020-09-08 Iniziato Credit Suisse Neutral
2020-09-08 Iniziato Jefferies Hold
Mostra tutto

Curevac N V Borsa (CVAC) Ultime notizie

pulisher
Jul 24, 2025

Is CureVac N.V. a good long term investmentMarket-beating returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

CureVac N.V.Finanzen.net - Finanzen.net

Jul 24, 2025
pulisher
Jul 24, 2025

What drives CureVac N.V. stock priceFastest-growing stock picks - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about CureVac N.V. stockExponential return rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

CureVac N.V. Stock Analysis and ForecastUnmatched profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech - MSN

Jul 15, 2025
pulisher
Jul 14, 2025

CureVac: Pipeline pruning’s nasty effect - MarketScreener

Jul 14, 2025
pulisher
Jul 09, 2025

CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why - Insider Monkey

Jul 09, 2025
pulisher
Jul 05, 2025

Tesla chief Elon Musk teams up with Covid-19 player CureVac to build ‘RNA microfactories’ - Endpoints News

Jul 05, 2025
pulisher
Jun 26, 2025

CureVac Announces Key Resolutions from Annual Shareholders Meeting - TipRanks

Jun 26, 2025
pulisher
Jun 26, 2025

CureVac (CVAC) Downgraded by UBS as Acquisition Looms | CVAC Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 24, 2025

CureVac Announces Key Appointments and Auditor Reappointment at Annual Meeting - TipRanks

Jun 24, 2025
pulisher
Jun 18, 2025

Private-Public Deal Momentum Grows, Yet Megamergers Stay Elusive - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

BioNTech SE Announces Acquisition of CureVac N.V. - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Germany: BioNTech to acquire CureVac in all-stock transaction - Investors in Healthcare

Jun 17, 2025
pulisher
Jun 16, 2025

BioNTech to Acquire CureVac in Strategic Move - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

5 Stocks To Ride The German Market RallyCureVac (NASDAQ:CVAC), BioNTech (NASDAQ:BNTX) - Benzinga

Jun 16, 2025
pulisher
Jun 15, 2025

BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction - Global Legal Chronicle

Jun 15, 2025
pulisher
Jun 15, 2025

There's No Escaping CureVac N.V.'s (NASDAQ:CVAC) Muted Revenues Despite A 50% Share Price Rise - simplywall.st

Jun 15, 2025
pulisher
Jun 14, 2025

CureVac’s SWOT analysis: mRNA pioneer’s stock faces pivotal year ahead By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of - Bluefield Daily Telegraph

Jun 13, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech CureVac Acquisition Boosts Cancer Drug Pipeline - Industry Leaders Magazine

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac (CVAC) Receives Downgrade and Price Target Reduction fro - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

Jefferies cuts CureVac stock rating to hold on BioNTech acquisition By Investing.com - Investing.com UK

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech: Oddo BHF raises target price - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech to buy CureVac in USD 1.25 billion all-stock deal - Medical Dialogues

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac Stock: BioNTech's Billion-Dollar Takeover Bid - sharewise

Jun 13, 2025

Curevac N V Azioni (CVAC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):